Doctors across the country, including UT Health San Antonio physicians, are hopeful that convalescent plasma can now be used as an effective therapy in the fight against the coronavirus.
Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 and is being studied in clinical trials at University Hospital.
It’s important for the public to keep their cancer screenings, tests and treatments during this time. In this pre-recorded message, Ruben Mesa, M.D., FACP, explains that the Mays Cancer Center is open and safe for patients.
Keeping you informed about the latest in research, patient care and academics at The University of Texas Health Science Center at San Antonio, now called UT Health San Antonio.